| Literature DB >> 26348924 |
Aldrin Kay-Yuen Yim1, Johanna Wing-Hang Wong2, Yee-Shan Ku2, Hao Qin1, Ting-Fung Chan1, Hon-Ming Lam2.
Abstract
Differential gene expression profiles often provide important clues for gene functions. While reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) is an important tool, the validity of the results depends heavily on the choice of proper reference genes. In this study, we employed new and published RNA-sequencing (RNA-Seq) datasets (26 sequencing libraries in total) to evaluate reference genes reported in previous soybean studies. In silico PCR showed that 13 out of 37 previously reported primer sets have multiple targets, and 4 of them have amplicons with different sizes. Using a probabilistic approach, we identified new and improved candidate reference genes. We further performed 2 validation tests (with 26 RNA samples) on 8 commonly used reference genes and 7 newly identified candidates, using RT-qPCR. In general, the new candidate reference genes exhibited more stable expression levels under the tested experimental conditions. The three newly identified candidate reference genes Bic-C2, F-box protein2, and VPS-like gave the best overall performance, together with the commonly used ELF1b. It is expected that the proposed probabilistic model could serve as an important tool to identify stable reference genes when more soybean RNA-Seq data from different growth stages and treatments are used.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26348924 PMCID: PMC4562714 DOI: 10.1371/journal.pone.0136343
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Evaluation of previously reported reference genes and new candidate reference genes.
A boxplot of RNA-Seq data showing the expression levels of 37 previously reported primer sets from 28 known reference genes and 7 new candidate reference genes. The expression level of each target was shown. White boxes: Group 1 RNA-Seq data; Grey boxes: Group 2 RNA-Seq data. Primer sets with multiple targets were marked with brackets. Primer sets marked in red were chosen for RT-qPCR validation.
RT-qPCR primer sets used in this study and their target genes.
| Gene name | Gene ID | Primer name | Forward primer (5’-3’) | Reverse primer (5’-3’) |
|---|---|---|---|---|
|
| Glyma.08G349900 |
|
|
|
|
| Glyma.03G064800 |
|
|
|
|
| Glyma.02G273700 |
|
|
|
|
| Glyma.08G013800 |
|
|
|
|
| Glyma.08G113000 |
|
|
|
|
| Glyma.05G117600 |
|
|
|
|
| Glyma.09G196600 |
|
|
|
|
| Glyma.18G290800; Glyma.02G091900 |
|
|
|
|
| Glyma.19G147900 |
|
|
|
|
| Glyma.12G024700 |
|
|
|
|
| Glyma.05G114900; Glyma.19G052400 |
|
|
|
|
| Glyma.02G276600; Glyma.14G039100 |
|
|
|
|
| Glyma.16G063200 |
|
|
|
|
| Glyma.03G124400; Glyma.19G127700 |
|
|
|
|
| Glyma.07G199900 |
|
|
|
* Commonly used reference genes.
Evaluation of selected reference genes using RNA-Seq data.
| Group 1 | Group 2 | ||||||
|---|---|---|---|---|---|---|---|
| Gene name | Gene ID | Coefficient of Variation | Shapiro test p-value | KS-test p-value | Coefficient of Variation | Shapiro test p-value | KS-test p-value |
|
| Glyma.02G273700 | 0.094 | 0.819 | 0.992 | 0.197 | 0.960 | 0.981 |
|
| Glyma.08G113000 | 0.158 | 0.588 | 0.896 | 0.198 | 0.974 | 0.995 |
|
| Glyma.08G349900 | 0.106 | 0.390 | 0.747 | 0.152 | 0.026 | 0.460 |
|
| Glyma.03G064800 | 0.193 | 0.443 | 0.942 | 0.177 | 0.883 | 0.995 |
|
| Glyma.09G196600 | 0.137 | 0.754 | 0.938 | 0.183 | 0.697 | 0.995 |
|
| Glyma.05G117600 | 0.181 | 0.140 | 0.663 | 0.137 | 0.081 | 0.760 |
|
| Glyma.08G013800 | 0.161 | 0.924 | 0.994 | 0.236 | 0.187 | 0.813 |
|
| Glyma.16G063200 | 0.805 | 0.096 | 0.573 | 1.269 | 1.228E-05 | 0.130 |
|
| Glyma.19G147900 | 0.294 | 0.507 | 0.848 | 0.776 | 1.588E-05 | 0.096 |
|
| Glyma.07G199900 | 0.652 | 0.087 | 0.389 | 0.856 | 2.837E-04 | 0.119 |
|
| Glyma.03G124400 | 0.459 | 0.003 | 0.369 | 0.730 | 0.001 | 0.301 |
|
| Glyma.19G127700 | 0.271 | 0.041 | 0.581 | 0.528 | 0.177 | 0.629 |
|
| Glyma.18G290800 | 0.315 | 0.999 | 0.999 | 0.730 | 0.000 | 0.152 |
|
| Glyma.02G091900 | 0.447 | 0.563 | 0.931 | 0.597 | 0.001 | 0.133 |
|
| Glyma.14G039100 | 0.382 | 0.061 | 0.732 | 0.555 | 0.001 | 0.223 |
|
| Glyma.02G276600 | 0.460 | 0.133 | 0.734 | 0.423 | 0.320 | 0.725 |
|
| Glyma.05G114900 | 0.140 | 0.609 | 0.876 | 0.414 | 0.004 | 0.488 |
|
| Glyma.19G052400 | 0.159 | 0.387 | 0.900 | 0.340 | 0.027 | 0.466 |
|
| Glyma.12G024700 | 0.278 | 0.210 | 0.582 | 0.361 | 0.618 | 0.929 |
* Commonly used reference genes.
Evaluation of reference genes using RT-qPCR assays.
| Gene name | Assay 1 | Assay 2 | All samples | |||
|---|---|---|---|---|---|---|
| Mean Ct | Mean ΔCt | Mean Ct | Mean ΔCt | Mean Ct | Mean ΔCt | |
|
| 28.55 | 0.85 | 28.92 | 1.22 | 28.84 | 1.13 |
|
| 29.37 | 1.08 | 29.48 | 1.20 | 29.46 | 1.17 |
|
| 29.76 | 1.06 | 29.98 | 1.28 | 29.93 | 1.23 |
|
| 26.05 | 1.75 | 25.40 | 1.11 | 25.55 | 1.25 |
|
| 29.48 | 0.36 | 30.77 | 1.65 | 30.47 | 1.35 |
|
| 28.50 | 0.44 | 29.72 | 1.66 | 29.43 | 1.38 |
|
| 28.94 | 0.87 | 29.83 | 1.75 | 29.62 | 1.55 |
|
| 23.01 | 0.99 | 23.80 | 1.78 | 23.62 | 1.60 |
|
| 23.36 | 1.49 | 23.58 | 1.71 | 23.53 | 1.66 |
|
| 28.98 | 1.20 | 29.59 | 1.81 | 29.45 | 1.67 |
|
| 24.13 | 1.96 | 23.99 | 1.82 | 24.02 | 1.85 |
|
| 24.88 | 1.11 | 25.96 | 2.19 | 25.71 | 1.94 |
|
| 24.18 | 2.65 | 23.32 | 1.80 | 23.52 | 1.99 |
|
| 24.06 | 1.08 | 25.38 | 2.40 | 25.08 | 2.09 |
|
| 26.28 | 3.39 | 26.37 | 3.48 | 26.35 | 3.46 |
aAssay 1: Tissue types; Assay 2: Stress treatments; All samples: all samples from assay 1 and assay 2.
* Commonly used reference genes,
Fig 2Geomeans of ranking values of (A) tissue types, (B) stress treatments, and (C) all samples.
Genes are arranged in descending order of stability from left to right. Commonly used reference genes are marked with asterisk (*).
Ranking of reference genes based on the geomean of stability values.
|
|
|
|
|
|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Commonly used reference genes.